NCOA3 and breast cancer: A recent study indicated that decreased HER-2 signaling inhibited SRC-3 phosphorylation at T24, S543, S857 and S860, and the enhanced HER-2 signaling cooperated with phosphorylated SRC-3 to promote breast cancer cell proliferation [28].